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ABSTRACT
This study investigated the differences among Enterococcus faecalis isolates from the intestinal
compartment of healthy volunteers (n = 36), intensive care unit (ICU) patients (n = 29) and blood
isolates (n = 31) from the same institution, in comparison with seven epidemic clones from other
institutions. In general, isolates from colonised ICU patients and from bacteraemic patients showed
higher rates of antimicrobial resistance than isolates from colonised healthy volunteers, particularly for
erythromycin and aminoglycosides. The proportion of isolates ⁄ clone was 1.05 in the community, 2.63 in
the ICU, and 1.47 among bacteraemic cases, suggesting low clonal variation in ICUs. Two clones, RENC1
and RENC2, were frequently found as intestinal colonisers of ICU patients, and RENC1 was also found
to colonise healthy volunteers. These two clones were a cause of bacteraemia in the institution studied,
and RENC2 was also detected in various other Spanish hospitals. Both RENC1 and RENC2 were esp+,
bacteriocin producers, and were resistant to all antibiotics tested except vancomycin and ampicillin.
RENC1 produced haemolysin whereas RENC2 produced protease. The ace, agg, cylA, esp and gelE genes
were more common among colonising strains from ICU patients than among isolates from individuals
in the community. In both colonised groups (ICUs and the community), 40–50% of isolates harbouring
the gelE and cylA genes did not express the corresponding phenotypes. Thus, the study indicated that
particular E. faecalis clones might be well-adapted to hospital environments, and that surveillance
should be directed specifically towards rapid detection of these disseminating clones in order to prevent
infections and clonal spread.
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INTRODUCTION
Enterococcus spp. have traditionally been consid-
ered to be normal members of the human gut
microbiota that are involved occasionally in hu-
man infections. In the nosocomial setting, the
origin of enterococcal infections has been conven-
tionally attributed to the resident strains in each
patient’s gut flora. However, epidemiological
studies designed to control the spread of
multiresistant strains, particularly those that are
vancomycin-resistant, have demonstrated the
importance of cross-transmission of enterococci
among inpatients, carried by hands, or fomites [1–
4], and also among humans and animals [5]. The
current concept of enterococcal epidemiology
requires an efficient enterococcal circulation
among different ecological niches, including the
environment, the animal gut, the human gut in
the community, and hospital patients. Neverthe-
less, genetic differences can be found among
strains recovered from these ecological compart-
ments, and molecular epidemiological studies of
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Enterococcus faecium have revealed the existence of
a hospital-adapted genetic sub-population that is
clearly distinct from the community and animal
reservoirs [6].
The presence of specific genes associated with
virulence or invasiveness has been described
recently in enterococci recovered from infection
sites, and these have been considered presump-
tively to be pathogenic traits [7]. In general, these
traits should be absent (or very rare) in strains
colonising the gut of healthy volunteers, or in
food isolates [8]. Nevertheless, recent studies have
demonstrated the presence of virulence genes in
environmental and food isolates, although in such
cases these genes tend to remain phenotypically
silent [9–11].
Previous studies, mostly focused on vancomy-
cin-resistant enterococci (VRE), have explored the
genetic differences among colonising or patho-
genic strains, and have demonstrated that specific
clones are involved in outbreaks, particularly in
intensive care units (ICUs) or when affecting
several different institutions [12–16]. The present
study was designed to study prospectively the
differences in population structure and patho-
genic traits among Enterococcus faecalis isolates
colonising two different environments, namely
ICU patients and healthy volunteers in the com-
munity. In addition, the involvement of different
clones in invasive infections was studied in a set
of isolates causing bacteraemia or other forms of
invasive disease. Three epidemic clones from
hospitals located in different regions of Spain
were also investigated.
MATERIALS AND METHODS
Bacterial strains and sampling process
Rectal swabs from 21 inpatients in four ICUs located in
different areas of the Ramo´n y Cajal University Hospital in
Madrid, Spain (medicine n = 1; general surgery n = 11; car-
diovascular surgery n = 1; paediatric cardiology n = 8) were
collected prospectively between March and May 2001. In
parallel, faecal samples were obtained from 36 healthy volun-
teers (20 males and 16 females) with no previous exposure to
antibiotics or treatment for at least 6 months. Only one isolate
per patient was retained.
Rectal swabs (or 0.5 g of faeces from the healthy volunteers)
were suspended in 1 mL or 5 mL of saline, respectively, and
100-lL aliquots were inoculated on m-Enterococcus agar (Difco,
Detroit, MI, USA) with and without antibiotics (gentamicin
125 mg ⁄L, kanamycin 256 mg ⁄L, streptomycin 512 mg ⁄L,
tetracycline 4 mg ⁄L, vancomycin 6 mg ⁄L, erythromycin
2 mg ⁄L or ampicillin 10 mg ⁄L). To enhance the recovery of
vancomycin-resistant enterococci (VRE), samples were also
pre-enriched in brain-heart infusion (BHI) broth (Difco) con-
taining vancomycin 6 mg ⁄L. Five colonies of each morphology
were selected initially, but only one colony of each resistance
phenotype and morphology was finally studied. Thirty-one
enterococcal isolates from blood samples recovered in the
same hospital during 2001, and seven epidemic E. faecalis
clones causing invasive infections in six hospitals in the
Spanish provinces of Galicia [17], Mallorca [18], Asturias,
Catalun˜a, La Rioja and Zaragoza [14] were also studied.
Bacterial identification
The presence of the E. faecalis antigen A gene (efaAfs) was
investigated by PCR using primers efaAfs-1 (5¢-GACAGA-
CCCTCACGAATA) and efaAfs-2 (5¢-AGTTCATCATGCTGT-
AGTA) and the conditions described previously [9]. The blood
isolates were also identified using the WIDER Automatic
System (Francisco Soria Melguizo S.A, Madrid, Spain).
Susceptibility testing
Susceptibility to gentamicin, kanamycin, streptomycin, ery-
thromycin, clindamycin, tetracycline, minocycline, ampicillin,
vancomycin, teicoplanin, quinupristin-dalfopristin, chloram-
phenicol, linezolid and moxifloxacin was determined by the
agar dilution method, according to CLSI guidelines [19] and
susceptibility breakpoints [20]. E. faecalis ATCC 29212 was
used as a control strain. Antibiotics were purchased from
Sigma Chemical Co. (St Louis, MO, USA) or were provided by
their respective manufacturers.
Presence of virulence factors
The presence of the ace [8], agg, cylA, esp, gelE and efaAfs [9]
genes, coding for adhesin to collagen, aggregation substance,
cytolysin ⁄haemolysin, surface protein, gelatinase production
and E. faecalis antigen A, respectively, was investigated by PCR
using primers and conditions described previously [8,9]. The
respective amplicons generated from the colonising 4Er1
E. faecalis strain (RENC2 clone) were sequenced and used as
positive controls in each PCR. Production of haemolysin was
determined following growth on Tryptic Soy Agar (TSA;
Difco) containing horse blood 5% w ⁄v, with a clear zone of
b-haemolysis considered to be a positive reaction. Protease
activity was determined on TSA containing skimmed milk
1.5% w ⁄v, with a clear halo around the colonies after
incubation for 24 h at 37C considered to be a positive
reaction. Bacteriocin production was tested as described
previously [21], with plates being incubated at 37C for 48 h
and then examined for inhibition zones around the strains.
Pulsed-field gel electrophoresis (PFGE)
Chromosomal DNA was prepared as described previously
[22], digested with SmaI, and analysed following electrophor-
esis (CHEF DR-II apparatus; Bio-Rad, Hercules, CA, USA) in
an agarose 1.2% w ⁄v gel with 0.5 · TBE buffer (89 mM Tris,
89 mM boric acid, 2 mM EDTA, pH 8) for 24 h at 6 V ⁄ cm2 and
a ramped pulse time of 1–35 s. PFGE results were interpreted
according to the criteria proposed by Tenover et al. [23], and by
means of Phoretrix v.5.0 software (Bio-Rad) using the Dice
coefficient [24]. The genetic relatedness among the isolates of
this study was compared with an existing Phoretrix database
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that included E. faecalis isolates from food-handlers and animal
faeces.
Statistical analysis
Statistical significance of comparison proportions was calcula-
ted by the chi-square test, with quantitative values compared
by Student’s t-test; p values < 0.05 were considered to be
statistically significant.
RESULTS
Isolates colonising ICU patients
Rectal swabs from 21 ICU patients yielded a total
of 29 E. faecalis isolates. The antibiotic resistances
found in these isolates are shown in Table 1. In
general, high percentages of antibiotic resistance
were observed, particularly for tetracycline
(96.5%), erythromycin (90%), chloramphenicol
(62%) and aminoglycosides (high-level resistance
(HLR) to gentamicin, 65%; HLR to kanamycin,
86%; and HLR to streptomycin, 83%). Resistance
to glycopeptides, ampicillin or linezolid was not
detected.
In total, 11 different E. faecalis PFGE clones
were identified among the ICU isolates. Nine of
these clones showed co-resistance to aminoglyco-
sides, erythromycin and tetracycline. The ace, agg,
esp and gelE virulence genes were detected in 73%
of the clones, while cylA was only present in 45%
(Table 2). Although gelE and cylA were detected
in eight (73%) and five (45%) PFGE clones,
respectively, protease and haemolysin production
were detected under laboratory conditions in only
five (45%) and three (27%) of the clones, respect-
ively. Bacteriocin production was detected in
eight (73%) of the 11 clones.
Two of the 11 E. faecalis PFGE clones detected
among the ICU patients proved to be widespread
in the institution studied. The RENC1 clone,
represented by 11 isolates recovered from all four
of the ICUs studied, colonised 52% of ICU
patients. The RENC2 clone, represented by five
isolates from two ICUs, colonised 23% of ICU
patients. Only one patient was co-colonised with
both the RENC1 and the RENC2 clones.
Isolates colonising healthy volunteers
The antimicrobial resistance rates among the 36
E. faecalis isolates from healthy volunteers in the
community were low in comparison with the
ICU isolates (Table 1), especially for erythromycin
(p < 0.00001), chloramphenicol (p 0.005), HLR to
gentamicin (p < 0.00001), HLR to kanamycin
(p < 0.00001) and HLR to streptomycin (p <
0.00001). Only resistance to tetracycline was high
(p 0.01). Resistance to ampicillin, moxifloxacin,
linezolid or glycopeptides was not observed.
PFGE revealed a high genetic diversity among
these isolates, with 34 different clones among the
36 E. faecalis isolates. Only one of these clones was
related closely to the widespread hospital RENC1
clonal type, with two band differences, and no
clones related to RENC2 were encountered. The
community RENC1 strain was susceptible to all
antibiotics tested, except tetracycline, and only the
ace virulence gene was detected (Table 3).
Except for efaAfs, the prevalence of the different
virulence genes was relatively low (20–38%) in 22
of the 34 different community-derived clones
(Table 2). The frequency of bacteriocin, protease
Table 1. Antibiotic resistance among enterococcal isolates
cultured from healthy volunteers (HV), intensive care unit
(ICU) patients or bloodstream infections
Antimicrobial agent
Colonising
HV
(36 isolates)
Colonising
ICU
(29 isolates)
Blood
(31 isolates)
n % n % n %
Erythromycin 10 27.7 26 89.6 27 87.1
Ampicillin 0 0 0 0 0 0
Moxifloxacin 0 0 11 37.9 1 3.2
Linezolid 0 0 0 0 0 0
Chloramphenicol 10 27.7 18 62 10 32.2
Tetracycline 27 75 28 96.5 9 29
Minocycline 20 55.5 17 58.6 ND –
Vancomycin 0 0 0 0 0 0
Teicoplanin 0 0 0 0 0 0
HLR gentamicin 1 2.7 19 65.5 12 38.7
HLR kanamycin 9 25 25 86.2 30 96.7
HLR streptomycin 8 22.2 24 82.7 16 51.6
ND, not determined; HLR, high-level resistance.
Table 2. Virulence factors identified in the enterococcal
isolates from healthy volunteers (HV), intensive care unit
(ICU) patients or bloodstream infections
Virulence factor
Colonising
HV
(34 clones)
Colonising
ICU
(11 clones)
Blood
(21 clones)
n % n % n %
ace 9 26.4 8 72.7 15 71.4
agg 9 26.4 8 72.7 10 47.6
cylA 7 20.5 5 45.4 2 9.5
efaA 34 100 11 100 21 100
esp 12 35.2 8 72.7 11 52.3
gelE 13 38.2 8 72.7 18 85.7
Bacteriocin production 22 64.7 8 72.7 18 85.7
Protease production 7 20.5 5 45.4 11 52.3
Haemolysin production 4 11.7 3 27.2 2 9.5
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or haemolysin production was lower than among
ICU isolates, although statistical significance was
not reached. As with the ICU clones, protease and
haemolysin production under laboratory condi-
tions was detected only in a sub-set of isolates
carrying the gelE and cylA genes (seven of 13, and
four of seven isolates, respectively).
Bloodstream isolates
Twenty-one different clones were distinguished
among the 31 E. faecalis isolates from blood. All
isolates identified as E. faecalis by the Wider
System were positive by PCR for the efaA gene.
The ICU-derived epidemic RENC1 and RENC2
clones were also identified among the blood
isolates from one (3%) and eight (26%) patients,
respectively (Table 3). No differences in the anti-
biotic resistance markers or the presence of
virulence factors were detected among the colo-
nising or invasive isolates that belonged to the
same clone. RENC1 carried the haemolysin gene
cylA, and the phenotypic expression of this gene
was detected, while all isolates belonging to the
RENC2 clone were consistently negative for this
virulence factor. Four clones colonising healthy
volunteers were related genetically to clones
associated with cases of bacteraemia.
The antibiotic resistance rates, the prevalence of
virulence genes, and the production of virulence
factors among blood isolates are listed in Tables 1
and 2. In general, lower percentages of antibiotic
resistance were observed among the isolates caus-
ing bacteraemia than among the faecal isolates
colonising ICU inpatients; however, resistance was
higher than among the isolates from patients in the
community. Statistically significant differences for
resistance to tetracycline (p < 0.00001), chloram-
phenicol (p 0.02), and HLR to gentamicin (p 0.04)
were observed between the isolates causing
bacteraemia and those colonising ICU patients.
The same trend was true for virulence genes, but
only the lower prevalence of the cylA gene among
the blood isolates was statistically significant
(p < 0.00001).
Among the E. faecalis epidemic strains causing
invasive infections in six Spanish hospitals in
different regions, the RENC2 clone was closely
related (only one different band) [23] to the
epidemic clones from La Corun˜a [17] and from
Palma de Mallorca [18]. However, it is important
to note that the epidemic clones from La Corun˜a
and Palma de Mallorca were resistant to vanco-
mycin, whereas the RENC2 clone from Madrid
was susceptible. Differences in the other antibiotic
susceptibility patterns or the presence of viru-
lence genes were not observed, except that the
Palma de Mallorca clone was susceptible to
tetracycline.
DISCUSSION
During the last decade, many studies of VRE
epidemiology have shown that particular clones
are capable of intra- and inter-hospital dissemin-
ation and cause most outbreaks of nosocomial
enterococcal infection [25]. Presumably, these
clones originated from the community and, once
introduced into hospitals, adapted progressively,
probably favoured by the acquisition of antibiotic
resistance genes and virulence factors. Once a
given threshold is reached, these hospital-adap-
ted clones were able to flow back into the
community or the environment [26]. Hospital re-
acquisition of such clones after community or
environmental exposure completes the epidemio-
logical loop. However, the epidemiological circu-
lation of particular clones has been poorly studied
to date, and particularly so in the case of glyco-
peptide-susceptible isolates.
Table 3. Main characteristics of the RENC1 and RENC2 clones of Enterococcus faecalis
PFGE group Origin No. isolates Antibiotic susceptibility Virulence factors
RENC1 Colonising ICU 10 HLR-Gm, HLR-Km, HLR-Sm, Tet, Er Bac, Hem, ace, agg, cylA, esp, gelE
Blood 1 HLR-Gm, HLR-Km, HLR-Sm, Tet, Er Bac, Hem, ace, agg, cylA, esp, gelE
RENC1¢a Colonising ICU 1 HLR-Km, HLR-Sm, Tet, Er Bac, Hem, ace, agg, cylA, esp, gelE
RENC1¢¢b Colonising HV 1 Tet ace
RENC2 Blood 1 HLR-Km, HLR-Sm, Tet, Er Bac, ace, agg, esp, gelE
Colonising ICU 5 HLR-Km, HLR-Sm, Tet, Er Bac, ace, agg, esp, gelE
RENC2¢a Blood 7 HLR-Km, HLR-Sm, Tet, Er Bac, ace, agg, esp, gelE
HLR-Gm, high-level resistance to gentamicin; HLR-Km, high-level resistance to kanamycin; HLR-Sm, high-level resistance to streptomycin; Tet, tetracycline; Er, erythromycin;
Bac, bacteriocin production; Hem, haemolysin production.
aRENC1¢ and C2¢ showed two different pulsed-field gel electrophoresis (PFGE) bands compared with the RENC1 and C2 clones.
bRENC1¢¢ showed three different PFGE bands compared with RENC1.
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The present study investigated vancomycin-
susceptible E. faecalis populations in faecal isolates
from patients admitted to four independent ICUs
in one hospital, and also from healthy volunteers.
These colonising isolates were compared with
contemporary isolates from blood in order to
identify epidemiological trends. Using PFGE ana-
lysis, different degrees of genetic diversity were
observed among isolates recovered from different
origins. The proportion of isolates ⁄ clone was 2.63
in ICUs, 1.47 among bacteraemic cases, and 1.05
in the community, suggesting a clonal condensa-
tion in ICUs. The relatively high clonal diversity
in blood isolates suggests that numerous clones
are able to cause invasive infection.
The results also indicated that some clones,
such as RENC1 and RENC2, are widespread as
intestinal colonisers of ICU patients and also
among invasive isolates. The same E. faecalis clone
(RENC2) was found as a cause of bacteraemia in
hospitals far from Madrid, i.e., La Corun˜a in the
north-west of Spain [17] and Palma de Mallorca in
the east [18]. This clone was not detected among
the isolates colonising the healthy volunteers.
Virulence genes were detected more frequently
among ICU isolates than among invasive isolates,
suggesting that the presence of the virulence
genes analysed was not necessarily linked to
pathogenicity. Comparing only the colonising
isolates, virulence genes were more frequent
among isolates from ICU patients than among
those from healthy volunteers, with the results for
ace, agg, cylA, esp and gelE being statistically
significant. None of the invasive isolates that
belonged to the RENC2 clone carried the cylA
gene or displayed corresponding haemolysin
production, whereas all isolates from the RENC1
clone colonising the intestine carried and ex-
pressed this virulence factor. Moreover, while
ICU isolates harboured the gelE or cylA genes
more frequently than isolates from community-
based patients, the proportion of isolates carrying
these genes and expressing them phenotypically
was similar in both groups. These genes may have
a biological cost outside the hospital, perhaps also
in association with environmental factors and ⁄ or
the quorum-sensing mechanism for autoinduced
cylR1 and cylR2 regulator genes [27]. The active
cylA protein consists of two subunits produced by
the cylM gene that are related to bacteriocins
classified as lantibiotics [28]. If these factors were
important for hospital maintenance, both a higher
frequency of genes and a higher rate of pheno-
typically expressed genes might be expected in
hospitals. There was a relatively low percentage
of haemolysin production among blood isolates in
comparison with both groups of faecal isolates.
As expected, the frequency of antibiotic resist-
ance was much higher among blood isolates than
among faecal isolates from the community, but
surprisingly, the faecal ICU isolates had the
highest percentages of resistance, with statisti-
cally higher levels of resistance to erythromycin,
moxifloxacin, chloramphenicol, tetracycline and
HLR to gentamicin. The HLR to gentamicin
among E. faecalis isolates colonising ICU patients
in this study was much higher (65.5%) than the
figure of 20% reported in Sweden [29,30]. Anti-
biotic resistance may be considered to be both the
effect and the cause of the adaptation of certain
clones to the hospital setting. In practice, the most
likely antibiotics involved in the selection of ICU
clones are probably gentamicin and fluoroquino-
lones.
Overall, the present study demonstrated that
specific E. faecalis clones might be well-adapted to
and disseminated in hospital environments, not
only causing infection, but also colonising inpa-
tients. Surveillance of resistant E. faecalis should
be targeted specifically at the rapid detection of
these highly adapted clones in order to prevent
infections and further clonal spread of antibiotic-
resistant E. faecalis strains in the hospital. The
development of new molecular typing tools such
as multilocus sequence typing (44th Interscience
Conference on Antimicrobial Agents and Chemo-
therapy, abstract K-371), will provide the oppor-
tunity to evaluate the global population structure
of E. faecalis, including all ecological and geo-
graphical compartments.
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